A compact and simple method of achieving differential transgene expression by exploiting translational readthrough

The development of multicistronic vectors enabling differential transgene expression is a goal of gene therapy and poses a significant engineering challenge. Current approaches rely on the insertion of long regulatory sequences that occupy valuable space in vectors, which have a finite and limited p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BioTechniques 2022-04, Vol.72 (4), p.143-154
Hauptverfasser: Sillibourne, James E, Agliardi, Giulia, Righi, Matteo, Smetanova, Katerina, Rowley, Grant, Speller, Simon, Dolor, Abigail, Lamb, Katarina, Allen, Christopher, Karattil, Rajeev, Parekh, Farhaan, Vargas, Frederick Arce, Thomas, Simon, Cordoba, Shaun, Pule, Martin
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The development of multicistronic vectors enabling differential transgene expression is a goal of gene therapy and poses a significant engineering challenge. Current approaches rely on the insertion of long regulatory sequences that occupy valuable space in vectors, which have a finite and limited packaging capacity. Here we describe a simple method of achieving differential transgene expression by inserting stop codons and translational readthrough motifs (TRMs) to suppress stop codon termination. TRMs reduced downstream transgene expression ∼sixfold to ∼140-fold, depending on the combination of stop codon and TRM used. We show that a TRM can facilitate the controlled secretion of the highly potent cytokine IL-12 at therapeutically beneficial levels in an aggressive immunocompetent mouse melanoma model to prevent tumor growth. Given their compact size (6 bp) and ease of introduction, we envisage that TRMs will be widely adopted in recombinant DNA engineering to facilitate differential transgene expression. We describe a simple method enabling two or more gene products to be synthesized in a cell at different levels to aid in the development of new therapeutics.
ISSN:0736-6205
1940-9818
DOI:10.2144/btn-2021-0079